PFIZER INC Effective Tax Rate
PFIZER INC (PFE) reported Effective Tax Rate of 62.40% for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-04
- PFIZER INC effective income tax rate reconciliation, percent for the quarter ending 2026-06-28 was 62.40%, a 1256.52% increase year-over-year.
- PFIZER INC effective income tax rate reconciliation, percent for the quarter ending 2026-03-29 was 14.60%.
- PFIZER INC effective income tax rate reconciliation, percent for the quarter ending 2025-09-28 was -6.50%, a 230.00% decline year-over-year.
- PFIZER INC effective income tax rate reconciliation, percent for the quarter ending 2025-06-29 was 4.60%, a 96.47% decline year-over-year.
- PFIZER INC effective income tax rate reconciliation, percent for fiscal 2025 was -3.50%.
- PFIZER INC effective income tax rate reconciliation, percent for fiscal 2024 was -0.40%.
- PFIZER INC effective income tax rate reconciliation, percent for fiscal 2023 was -105.40%, a 1197.92% decline from fiscal 2022.
- PFIZER INC effective income tax rate reconciliation, percent for fiscal 2022 was 9.60%, a 26.32% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | 62.40% 10-Q · filed 2026-08-04 | 2.10% 10-Q · filed 2026-08-04 | ||||||
| 2026-03-29 | 14.60% 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | -3.50% 10-K · filed 2026-02-26 | |||||||
| 2025-09-28 | -6.50% 10-Q · filed 2025-11-04 | -2.90% 10-Q · filed 2025-11-04 | ||||||
| 2025-06-29 | 4.60% 10-Q · filed 2026-08-04 | -0.80% 10-Q · filed 2026-08-04 | ||||||
| 2025-03-30 | -6.80% 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | -0.40% 10-K · filed 2026-02-26 | |||||||
| 2024-09-29 | 5.00% 10-Q · filed 2025-11-04 | 4.90% 10-Q · filed 2025-11-04 | ||||||
| 2024-06-30 | 130.20% 10-Q · filed 2025-08-05 | 4.80% 10-Q · filed 2025-08-05 | ||||||
| 2024-03-31 | 8.60% 10-Q · filed 2025-05-05 | |||||||
| 2023-12-31 | -105.40% 10-K · filed 2026-02-26 | |||||||
| 2023-10-01 | 28.80% 10-Q · filed 2024-11-04 | -6.20% 10-Q · filed 2024-11-04 | ||||||
| 2023-07-02 | -3.10% 10-Q · filed 2024-08-05 | 7.50% 10-Q · filed 2024-08-05 | ||||||
| 2023-04-02 | 11.40% 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | 9.60% 10-K · filed 2025-02-27 | |||||||
| 2022-10-02 | 4.00% 10-Q · filed 2023-11-08 | 10.50% 10-Q · filed 2023-11-08 | ||||||
| 2022-07-03 | 13.70% 10-Q · filed 2023-08-09 | 13.40% 10-Q · filed 2023-08-09 | ||||||
| 2022-04-03 | 12.90% 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 7.60% 10-K · filed 2024-02-22 | |||||||
| 2021-10-03 | -4.20% 10-Q · filed 2022-11-09 | 7.80% 10-Q · filed 2022-11-09 | 7.50% 10-Q · filed 2021-11-12 | |||||
| 2021-07-04 | 16.20% 10-Q · filed 2022-08-10 | 15.80% 10-Q · filed 2021-08-12 | 15.30% 10-Q · filed 2022-08-10 | 15.00% 10-Q · filed 2021-08-12 | ||||
| 2021-04-04 | 14.20% 10-Q · filed 2022-05-11 | |||||||
| 2020-12-31 | 5.30% 10-K · filed 2023-02-23 | 6.40% 10-K · filed 2021-02-25 | ||||||
| 2020-09-27 | -60.90% 10-Q · filed 2021-11-12 | -1.20% 10-Q · filed 2020-11-05 | 6.70% 10-Q · filed 2021-11-12 | 9.70% 10-Q · filed 2020-11-05 | ||||
| 2020-06-28 | 14.00% 10-Q · filed 2021-08-12 | 13.10% 10-Q · filed 2020-08-06 | 13.30% 10-Q · filed 2021-08-12 | 12.70% 10-Q · filed 2020-08-06 | ||||
| 2020-03-29 | 12.60% 10-Q · filed 2021-05-13 | 12.20% 10-Q · filed 2020-05-07 | ||||||
| 2019-12-31 | 5.20% 10-K · filed 2022-02-24 | 7.80% 10-K · filed 2020-02-27 | ||||||
| 2019-09-29 | 28.40% 10-Q · filed 2020-11-05 | 13.40% 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | -22.10% 10-Q · filed 2020-08-06 | -5.70% 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | 10.00% 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | -7.40% 10-K · filed 2021-02-25 | 5.90% 10-K · filed 2019-02-28 | ||||||
| 2018-09-30 | 1.60% 10-Q · filed 2019-11-07 | 9.90% 10-Q · filed 2019-11-07 | ||||||
| 2018-07-01 | 14.30% 10-Q · filed 2019-08-08 | 13.90% 10-Q · filed 2019-08-08 | ||||||
| 2018-04-01 | 13.50% 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | -73.50% 10-K · filed 2020-02-27 | |||||||
| 2017-10-01 | 20.30% 10-Q · filed 2018-11-08 | 20.10% 10-Q · filed 2018-11-08 | ||||||
| 2017-07-02 | 19.40% 10-Q · filed 2018-08-09 | 20.10% 10-Q · filed 2018-08-09 | ||||||
| 2017-04-02 | 20.80% 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | 13.40% 10-K · filed 2019-02-28 | |||||||
| 2016-10-02 | 15.50% 10-Q · filed 2017-11-09 | 17.70% 10-Q · filed 2016-11-10 | 14.60% 10-Q · filed 2017-11-09 | 15.80% 10-Q · filed 2016-11-10 | ||||
| 2016-07-03 | 14.40% 10-Q · filed 2017-08-10 | 15.60% 10-Q · filed 2016-08-11 | 14.40% 10-Q · filed 2017-08-10 | 15.20% 10-Q · filed 2016-08-11 | ||||
| 2016-04-03 | 14.40% 10-Q · filed 2017-05-11 | 15.00% 10-Q · filed 2016-05-12 | ||||||
| 2015-12-31 | 22.20% 10-K · filed 2018-02-22 | |||||||
| 2015-09-27 | 21.00% 10-Q · filed 2016-11-10 | 23.40% 10-Q · filed 2016-11-10 | ||||||
| 2015-06-28 | 25.60% 10-Q · filed 2016-08-11 | 24.30% 10-Q · filed 2016-08-11 | ||||||
| 2015-03-29 | 22.90% 10-Q · filed 2016-05-12 | |||||||
| 2014-12-31 | 25.50% 10-K · filed 2017-02-23 | |||||||
| 2014-09-28 | 25.40% 10-Q · filed 2015-11-05 | 24.70% 10-Q · filed 2015-11-05 | ||||||
| 2014-06-29 | 27.00% 10-Q · filed 2015-08-06 | 24.30% 10-Q · filed 2015-08-06 | ||||||
| 2014-03-30 | 20.40% 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | 27.40% 10-K · filed 2016-02-29 | |||||||
| 2013-09-29 | 27.60% 10-Q · filed 2014-11-06 | 30.60% 10-Q · filed 2014-11-06 | ||||||
| 2013-06-30 | 33.30% 10-Q · filed 2014-08-07 | 31.80% 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | 29.80% 10-Q · filed 2014-05-08 | 29.60% 10-Q · filed 2013-05-10 | ||||||
| 2012-12-31 | 19.80% 10-K · filed 2015-02-27 | 21.20% 10-K · filed 2013-02-28 | ||||||
| 2012-09-30 | -6.50% 10-Q · filed 2013-11-08 | -4.00% 10-Q · filed 2012-11-09 | 17.70% 10-Q · filed 2013-11-08 | 19.00% 10-Q · filed 2012-11-09 | ||||
| 2012-07-01 | 28.20% 10-Q · filed 2013-08-09 | 28.80% 10-Q · filed 2012-08-09 | 28.40% 10-Q · filed 2013-08-09 | 28.90% 10-Q · filed 2012-08-09 | ||||
| 2012-04-01 | 29.20% 10-Q · filed 2013-05-10 | 29.40% 10-Q · filed 2012-05-10 | ||||||
| 2011-12-31 | 31.50% 10-K · filed 2014-02-28 | |||||||
| 2011-10-02 | 34.30% 10-Q · filed 2012-11-09 | 33.70% 10-Q · filed 2011-11-10 | 31.20% 10-Q · filed 2012-11-09 | 30.80% 10-Q · filed 2011-11-10 | ||||
| 2011-07-03 | 29.70% 10-Q · filed 2011-08-11 | 29.50% 10-Q · filed 2012-08-09 | 29.20% 10-Q · filed 2011-08-11 | |||||
| 2011-04-03 | 28.70% 10-Q · filed 2012-05-10 | |||||||
| 2010-12-31 | 12.20% 10-K · filed 2013-02-28 | 11.90% 10-K · filed 2011-02-28 | ||||||
| 2010-10-03 | 39.50% 10-Q · filed 2011-11-10 | 39.20% 10-Q · filed 2010-11-12 | 37.30% 10-Q · filed 2011-11-10 | |||||
| 2010-07-04 | 37.50% 10-Q · filed 2011-08-11 | 37.40% 10-Q · filed 2010-08-12 | 36.90% 10-Q · filed 2011-08-11 | |||||
| 2010-04-04 | 36.00% 10-Q · filed 2011-05-12 | |||||||
| 2009-12-31 | 20.10% 10-K · filed 2012-02-28 | 20.30% 10-K · filed 2011-02-28 | ||||||
| 2009-09-27 | 27.50% 10-Q · filed 2010-11-12 | 27.30% 10-Q · filed 2010-11-12 | ||||||
| 2009-06-28 | 25.80% 10-Q · filed 2010-08-12 | 27.10% 10-Q · filed 2010-08-12 | ||||||
| 2008-12-31 | 17.00% 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |